Futureshock section
Biotech
Gene editing, drug discovery, longevity claims and the trials that test them.
-
FDA Approves Pfizer’s Talzenna Combo for HRR-Mutated Metastatic Prostate Cancer
Pfizer’s PARP inhibitor plus enzalutamide is now approved for HRR-mutated metastatic prostate cancer before resistance sets in. In TALAPRO-3 it cut the…
-
UK Pledges £100m for an AI Biosecurity Lab, Backed by £200m in AI Credits
Ahead of Wednesday’s Budget, the UK announced a £100m AI Biosecurity Lab backed by £200m in model credits, plus £120m more for…
-
AI Labs Go Shopping for Biology: Claude’s Scorpion Binders and OpenAI’s Orchestra
Anthropic says Claude designed 17 lab-confirmed binders against scorpion toxins, though not an antivenom. Same day, OpenAI bought drug-development software startup Orchestra…
-
FDA Approves Hibsago, a 24-Week Shot That Lets Some Hepatitis B Patients Stop
GSK’s bepirovirsen is the first antisense drug approved for chronic hepatitis B. In trials, 19% of patients kept the virus controlled after…